Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 3
2016 1
2017 2
2018 4
2019 2
2020 2
2021 1
2022 4
2023 3
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Silent progression in disease activity-free relapsing multiple sclerosis.
University of California, San Francisco MS-EPIC Team; Cree BAC, Hollenbach JA, Bove R, Kirkish G, Sacco S, Caverzasi E, Bischof A, Gundel T, Zhu AH, Papinutto N, Stern WA, Bevan C, Romeo A, Goodin DS, Gelfand JM, Graves J, Green AJ, Wilson MR, Zamvil SS, Zhao C, Gomez R, Ragan NR, Rush GQ, Barba P, Santaniello A, Baranzini SE, Oksenberg JR, Henry RG, Hauser SL. University of California, San Francisco MS-EPIC Team, et al. Among authors: stern wa. Ann Neurol. 2019 May;85(5):653-666. doi: 10.1002/ana.25463. Epub 2019 Mar 30. Ann Neurol. 2019. PMID: 30851128 Free PMC article.
Polygenic risk score association with multiple sclerosis susceptibility and phenotype in Europeans.
Shams H, Shao X, Santaniello A, Kirkish G, Harroud A, Ma Q, Isobe N; University of California San Francisco MS-EPIC Team; Schaefer CA, McCauley JL, Cree BAC, Didonna A, Baranzini SE, Patsopoulos NA, Hauser SL, Barcellos LF, Henry RG, Oksenberg JR. Shams H, et al. Brain. 2023 Feb 13;146(2):645-656. doi: 10.1093/brain/awac092. Brain. 2023. PMID: 35253861 Free PMC article.
Susceptibility-based imaging aids accurate distinction of pediatric-onset MS from myelin oligodendrocyte glycoprotein antibody-associated disease.
Sacco S, Virupakshaiah A, Papinutto N, Schoeps VA, Akula A, Zhao H, Arona J, Stern WA, Chong J, Hart J, Zamvil SS, Sati P, Henry RG, Waubant E. Sacco S, et al. Among authors: stern wa. Mult Scler. 2023 Dec;29(14):1736-1747. doi: 10.1177/13524585231204414. Epub 2023 Oct 28. Mult Scler. 2023. PMID: 37897254 Free PMC article.
Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis.
Bischof A, Papinutto N, Keshavan A, Rajesh A, Kirkish G, Zhang X, Mallott JM, Asteggiano C, Sacco S, Gundel TJ, Zhao C, Stern WA, Caverzasi E, Zhou Y, Gomez R, Ragan NR, Santaniello A, Zhu AH, Juwono J, Bevan CJ, Bove RM, Crabtree E, Gelfand JM, Goodin DS, Graves JS, Green AJ, Oksenberg JR, Waubant E, Wilson MR, Zamvil SS; University of California, San Francisco MS-EPIC Team; Cree BAC, Hauser SL, Henry RG. Bischof A, et al. Among authors: stern wa. Ann Neurol. 2022 Feb;91(2):268-281. doi: 10.1002/ana.26281. Epub 2022 Jan 4. Ann Neurol. 2022. PMID: 34878197 Free PMC article.
Reply to "Spinal Cord Atrophy Is a Preclinical Marker of Progressive MS".
Bischof A, Papinutto N, Keshavan A, Rajesh A, Kirkish G, Zhang X, Mallott JM, Asteggiano C, Sacco S, Gundel TJ, Zhao C, Stern WA, Caverzasi E, Zhou Y, Gomez R, Ragan NR, Santaniello A, Zhu AH, Juwono J, Bevan CJ, Bove RM, Crabtree-Hartman E, Gelfand JM, Goodin DS, Graves JS, Green AJ, Oksenberg JR, Waubant E, Wilson MR, Zamvil SS; University of California, San Francisco MS-EPIC Team; Cree BA, Hauser SL, Henry RG. Bischof A, et al. Among authors: stern wa. Ann Neurol. 2022 May;91(5):735-736. doi: 10.1002/ana.26340. Epub 2022 Mar 26. Ann Neurol. 2022. PMID: 35233827 Free PMC article. No abstract available.
Association of daily physical activity with brain volumes and cervical spinal cord areas in multiple sclerosis.
Block VJ, Cheng S, Juwono J, Cuneo R, Kirkish G, Alexander AM, Khan M, Akula A, Caverzasi E, Papinutto N, Stern WA, Pletcher MJ, Marcus GM, Olgin JE, Hauser SL, Gelfand JM, Bove R, Cree BA, Henry RG. Block VJ, et al. Among authors: stern wa. Mult Scler. 2023 Mar;29(3):363-373. doi: 10.1177/13524585221143726. Epub 2022 Dec 27. Mult Scler. 2023. PMID: 36573559 Free PMC article.
N-Acetyl Cysteine as a Neuroprotective Agent in Progressive Multiple Sclerosis (NACPMS) trial: Study protocol for a randomized, double-blind, placebo-controlled add-on phase 2 trial.
Schoeps VA, Graves JS, Stern WA, Zhang L, Nourbakhsh B, Mowry EM, Henry RG, Waubant E. Schoeps VA, et al. Among authors: stern wa. Contemp Clin Trials. 2022 Nov;122:106941. doi: 10.1016/j.cct.2022.106941. Epub 2022 Sep 28. Contemp Clin Trials. 2022. PMID: 36182028 Free article.
Long-term evolution of multiple sclerosis disability in the treatment era.
University of California, San Francisco MS-EPIC Team:; Cree BA, Gourraud PA, Oksenberg JR, Bevan C, Crabtree-Hartman E, Gelfand JM, Goodin DS, Graves J, Green AJ, Mowry E, Okuda DT, Pelletier D, von Büdingen HC, Zamvil SS, Agrawal A, Caillier S, Ciocca C, Gomez R, Kanner R, Lincoln R, Lizee A, Qualley P, Santaniello A, Suleiman L, Bucci M, Panara V, Papinutto N, Stern WA, Zhu AH, Cutter GR, Baranzini S, Henry RG, Hauser SL. University of California, San Francisco MS-EPIC Team:, et al. Among authors: stern wa. Ann Neurol. 2016 Oct;80(4):499-510. doi: 10.1002/ana.24747. Epub 2016 Aug 13. Ann Neurol. 2016. PMID: 27464262 Free PMC article.
20 results